Special Issue "Advances in Mycotoxin Research"
Deadline for manuscript submissions: closed (30 November 2009)
Dr. Jeffrey W. Cary
Molecular Biologist USDA, ARS, SRRC, 1100 Robert E. Lee Blvd., New Orleans, LA 70124-4305, USA
Phone: +1 504 286 4264
Fax: +1 504 286 4533
Interests: molecular biology of mycotoxin biosynthesis and regulation; fungal-host plant interactions; secondary metabolism; gene clusters; genomics; antifungal peptides; transgenic approaches to mycotoxin elimination in plants
Dr. Ana Calvo
Northern Illinois University, Biological Sciences, 1425 W. Lincoln Hwy Montgomery Hall, Dekalb, IL 60115, USA
Phone: +1 (815) 753-0451
Fax: +1 (815) 753-0461
Interests: Fungal development, Fungal secondary metabolism, mycotoxins, Aspergillus, gene regulation
Fungi produce a diverse array of secondary metabolites some of which have desirable antibiotic properties while others are harmful toxins. Mycotoxins can have adverse impacts on the health of humans and other animals as well as negative economic impacts on agriculture and associated industries. It is estimated that almost a third of the world’s food supply is contaminated with mycotoxins. Developing countries are often without the resources to detect and monitor mycotoxins in their food supplies and are therefore the hardest hit both economically and health-wise due to the presence of mycotoxins in agricultural crops. This special issue of Toxins is devoted to recent advances in mycotoxin research with emphasis placed on the most agriculturally relevant fungi and the mycotoxins they produce. These include aflatoxins produced mainly by Aspergillus flavus and A. parasiticus, trichothecenes produced mainly by Fusarium graminearum, fumonisins produced by Fusarium verticillioides and ochratoxin produced mainly by Aspergillus ochraceus and Penicillium verrucosum. Topics of interest will include the genetics and biology of fungal toxin production, mycotoxin detection, plant breeding and transgenic technologies for resistance, biocontrol, ecology/evolution of mycotoxigenic fungi, medically important mycotoxigenic fungi, and mycotoxin risk management and regulatory issues.
Ana Calvo, Ph. D.
Jeffrey W. Cary, Ph. D.
- secondary metabolites